How do we best incorporate ADCs into sequenced therapy for HER2 non-amplified breast cancer?

Name: How do we best incorporate ADCs into sequenced therapy for HER2 non-amplified breast cancer?
Start: 2027-09-20T10:15
End: 2027-09-20T11:45
Location: Fira Gran Via

ESMO Congress · 20 September 2027 · 10:15–11:45 · Almeria Auditorium - Hall 2

How do we best incorporate ADCs into sequenced therapy for HER2 non-amplified breast cancer? was a session at ESMO Congress on 20 September 2027 in Barcelona, with 3 speakers on record.

Speakers

Hope S. Rugo — Chair Professor, City of Hope Comprehensive Cancer Center
Sara A. Hurvitz — Speaker University of Washington
Jian Zhang — Speaker Fudan University Shanghai Cancer Center